209106976	209106976	CD	B-NP	O
|	|	NN	I-NP	O
NH	NH	NN	I-NP	O
|	|	NN	I-NP	O
00907967	00907967	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8105030	8105030	CD	B-NP	O
|	|	CC	I-NP	O
6/23/2006	6/23/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
internal	internal	JJ	I-NP	O
hemorrhoids	hemorrhoid	NNS	I-NP	O
,	,	,	O	O
nonbleeding	nonbleeding	JJ	B-NP	O
diverticuli	diverticuli	NNS	I-NP	O
,	,	,	O	O
gastritis	gastritis	NN	B-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/24/2006	3/24/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/27/2006	7/27/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
LINNELL	LINNELL	NNP	B-NP	O
,	,	,	O	O
FREDRIC	FREDRIC	NNP	B-NP	O
H	H	NNP	I-NP	O
100-68-32-5	100-68-32-5	:	O	O
Lake	Lake	NNP	B-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
4/3/06	4/3/06	CD	B-NP	O
AT	AT	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
FERNDEZ	FERNDEZ	NNP	B-NP	O
,	,	,	O	O
DALTON	DALTON	NNP	B-NP	O
DARRIN	DARRIN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NN	B-NP	B-DNA
200	200	CD	B-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
DAILY	DAILY	NNP	I-NP	I-DNA
CALCITRIOL	CALCITRIOL	NNP	I-NP	I-DNA
0.25	0.25	CD	I-NP	I-DNA
MCG	MCG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
DAILY	DAILY	NNP	I-NP	I-DNA
DICLOXACILLIN	DICLOXACILLIN	NNP	I-NP	I-DNA
500	500	CD	I-NP	I-DNA
MG	MG	NN	I-NP	I-DNA
PO	PO	NN	I-NP	I-DNA
QID	QID	NN	I-NP	I-DNA
X	X	SYM	B-NP	I-DNA
7	7	CD	I-NP	I-DNA
Days	Day	NNPS	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
7/21	7/21	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
COLACE	COLACE	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
DOCUSATE	DOCUSATE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
FOLATE	FOLATE	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FOLIC	FOLIC	NNP	I-NP	I-protein
ACID	ACID	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
1	1	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
DAILY	DAILY	NN	I-NP	I-protein
LASIX	LASIX	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
200	200	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QAM	QAM	NNP	I-NP	O
MAGNESIUM	MAGNESIUM	NNP	I-NP	O
GLUCONATE	GLUCONATE	NNP	I-NP	O
500	500	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
ZAROXOLYN	ZAROXOLYN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOLAZONE	METOLAZONE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

OXYCODONE	OXYCODONE	RB	B-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q8H	Q8H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Pain	Pain	NNP	I-NP	O
PHENOBARBITAL	PHENOBARBITAL	NNP	I-NP	O
64.8	64.8	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
OXYCONTIN	OXYCONTIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OXYCODONE	OXYCODONE	NNP	I-NP	O
CONTROLLED	CONTROLLED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q12H	Q12H	NNP	I-NP	O
LANTUS	LANTUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
37	37	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
7/21	7/21	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
LIPITOR	LIPITOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
REL	REL	NNP	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NNP	B-NP	O
KCL	KCL	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
AH	AH	NNP	B-NP	O
Potassium	Potassium	NNP	I-NP	O
Chloride	Chloride	NNP	I-NP	O
Policy	Policy	NNP	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
COLCHICINE	COLCHICINE	NN	I-NP	O
0.6	0.6	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
EVERY	EVERY	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DAY	DAY	NNP	I-NP	O
COUMADIN	COUMADIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
12.5	12.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
Friday	Friday	NNP	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/3/06	4/3/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
SERIOUS	SERIOUS	NNS	B-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PHENOBARBITAL	PHENOBARBITAL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PHENOBARBITAL	PHENOBARBITAL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
md	md	NN	I-NP	O
aware	aware	JJ	I-NP	O
COUMADIN	COUMADIN	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Tuesday	Tuesday	NNP	B-NP	O
,	,	,	O	O
Thursday	Thursday	NNP	B-NP	O
,	,	,	O	O
Saturday	Saturday	NNP	B-NP	O
,	,	,	O	O
Sunday	Sunday	NNP	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/3/06	4/3/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
SERIOUS	SERIOUS	NNS	B-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PHENOBARBITAL	PHENOBARBITAL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PHENOBARBITAL	PHENOBARBITAL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	I-NP	O
ACID	ACID	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CHILDREN	CHILDREN	NNP	I-NP	O
'S	'S	POS	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
81	81	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/3/06	4/3/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
IRON	IRON	NNP	I-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FERROUS	FERROUS	NNP	I-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
milk	milk	NN	I-NP	O
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	O
HUMALOG	HUMALOG	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
LISPRO	LISPRO	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
SC	SC	NN	I-NP	B-protein
AC+HS	AC+HS	NN	I-NP	I-protein
If	If	IN	B-SBAR	I-protein
BS	BS	NNP	B-NP	I-protein
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
400	400	CD	I-NP	O
SENNA	SENNA	NN	I-NP	O
TABLETS	TABLETS	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
SENNOSIDES	SENNOSIDES	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
2	2	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Constipation	Constipation	NNP	I-NP	O
NEXIUM	NEXIUM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr	Dr	NNP	B-NP	O
Chauncey	Chauncey	NNP	I-NP	O
Casal	Casal	NNP	I-NP	O
pcp	pcp	NN	I-NP	O
3/25	3/25	CD	I-NP	O
@	@	NN	I-NP	O
2	2	CD	B-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
level	level	NN	I-NP	O
Tues	Tues	NNP	I-NP	O
and	and	CC	I-NP	O
Fri	Fri	NNP	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
12/10/06	12/10/06	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
4	4	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Haroutunian	Haroutunian	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
MEPERIDINE	MEPERIDINE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
,	,	,	O	O
SILDENAFIL	SILDENAFIL	NNP	B-NP	O
CITRATE	CITRATE	NNP	I-NP	O
,	,	,	O	O
GABAPENTIN	GABAPENTIN	NNP	B-NP	B-protein
,	,	,	O	O
SPIRONOLACTONE	SPIRONOLACTONE	NN	B-NP	O
,	,	,	O	O
NITRATE	NITRATE	NN	B-NP	O
,	,	,	O	O
DIGOXIN	DIGOXIN	NN	B-NP	B-protein
,	,	,	O	O
AMLODIPINE	AMLODIPINE	NN	B-NP	O
,	,	,	O	O
ACE	ACE	NN	B-NP	O
Inhibitor	Inhibitor	NN	I-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
lower	low	JJR	B-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
internal	internal	JJ	I-NP	O
hemorrhoids	hemorrhoid	NNS	I-NP	O
,	,	,	O	O
nonbleeding	nonbleeding	JJ	B-NP	O
diverticuli	diverticuli	NNS	I-NP	O
,	,	,	O	O
gastritis	gastritis	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
VV	VV	NNP	I-NP	O
pacer	pacer	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CHF	CHF	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Afib	Afib	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CVA	CVA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
cerebrovascular	cerebrovascular	JJ	I-NP	O
accident	accident	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
IDDM	IDDM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Peripheral	Peripheral	JJ	I-NP	O
neuropathy	neuropathy	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
peripheral	peripheral	JJ	I-NP	O
neuropathy	neuropathy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Obesity	Obesity	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
PVD	PVD	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
peripheral	peripheral	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CRI	CRI	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
EGD/colonscopy-no	EGD/colonscopy-no	NNP	I-NP	O
active	active	JJ	I-NP	O
bleeding	bleeding	NN	I-NP	O
,	,	,	O	O
atrophic	atrophic	JJ	B-NP	O
gastritis	gastritis	NN	I-NP	O
,	,	,	O	O
scattered	scattered	JJ	B-NP	O
diverticuli	diverticuli	NNS	I-NP	O
,	,	,	O	O
small	small	JJ	B-NP	O
non	non	NN	I-NP	O
bleeding	bleed	VBG	B-VP	O
sessile	sessile	NN	B-NP	O
smooth	smooth	JJ	I-NP	O
polyps	polyp	NNS	I-NP	O
in	in	IN	B-PP	O
sigmoid	sigmoid	JJ	B-NP	O
,	,	,	I-NP	O
transverse	transverse	JJ	I-NP	O
colon	colon	NN	I-NP	O
,	,	,	O	O
descending	descend	VBG	B-VP	O
and	and	CC	I-VP	O
ascending	ascend	VBG	I-VP	O
colon	colon	NN	B-NP	O
,	,	,	O	O
moderate	moderate	JJ	B-NP	O
internal	internal	JJ	I-NP	O
hemmorrhoids	hemmorrhoid	NNS	I-NP	O
;	;	:	O	O
inadequate	inadequate	JJ	B-NP	O
prep	prep	NN	I-NP	O
,	,	,	O	O
small	small	JJ	B-NP	O
polyps	polyp	NNS	I-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
r/o	r/o	NN	B-NP	O
,	,	,	O	O
outpatient	outpatient	NN	B-NP	O
screening	screening	NN	I-NP	O
colonscopy	colonscopy	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
repeated	repeat	VBN	I-VP	O
2years	2year	NNS	B-NP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
day	day	NN	I-NP	O
prep	prep	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
KRASINSKI	KRASINSKI	NN	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
71	71	CD	B-NP	O
y/o	y/o	NN	I-NP	O
male	male	JJ	B-ADJP	O
with	with	IN	B-PP	O
extensive	extensive	JJ	B-NP	O
h/o	h/o	NN	I-NP	O
cv	cv	NN	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
for	for	IN	B-PP	O
afib	afib	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
recent	recent	JJ	B-NP	O
colonscopy	colonscopy	NN	I-NP	O
4/3	4/3	CD	I-NP	O
depicting	depict	VBG	I-NP	O
diverticuli	diverticuli	NNS	I-NP	O
,	,	,	O	O
polyps	polyp	NNS	B-NP	O
and	and	CC	O	O
internal	internal	JJ	B-NP	O
hemorrhoids	hemorrhoid	NNS	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
several	several	JJ	B-NP	O
week	week	NN	I-NP	O
h/o	h/o	NN	I-NP	O
rectal	rectal	JJ	I-NP	O
bleeding	bleeding	NN	I-NP	O
with	with	IN	B-PP	O
bowel	bowel	NN	B-NP	O
movements	movement	NNS	I-NP	O
with	with	IN	B-PP	O
several	several	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
large	large	JJ	B-NP	O
volume	volume	NN	I-NP	O
bloody	bloody	JJ	I-NP	O
discharge	discharge	NN	I-NP	O
,	,	,	O	O
painless	painless	JJ	B-ADJP	O
,	,	,	O	O
not	not	RB	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
BM	BM	NN	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
denies	deny	VBZ	B-VP	O
associated	associate	VBN	B-NP	O
symptoms	symptom	NNS	I-NP	O
no	no	DT	B-NP	O
sob	sob	NN	I-NP	B-protein
,	,	,	O	O
cp	cp	NN	B-NP	B-DNA
,	,	,	O	O
fevers	fever	NNS	B-NP	O
or	or	CC	I-NP	O
chills	chill	NNS	I-NP	O
.	.	.	O	O

Increasingly	Increasingly	RB	B-ADVP	O
constipated	constipate	VBN	B-VP	O
since	since	IN	B-PP	O
starting	start	VBG	B-VP	O
iron	iron	NN	B-NP	O
,	,	,	O	O
noticed	notice	VBD	B-VP	O
dark	dark	JJ	B-NP	O
stools	stool	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
h/o	h/o	NN	I-NP	B-protein
GIB	GIB	NN	I-NP	I-protein
or	or	CC	I-NP	O
dyspepsia	dyspepsia	NN	I-NP	O
or	or	CC	O	O
vomiting	vomit	VBG	B-VP	O
or	or	CC	I-VP	O
coughing	cough	VBG	I-VP	O
up	up	RP	B-PRT	O
blood	blood	NN	B-NP	O
.	.	.	O	O

Admission	Admission	NNP	B-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
ED	ED	VBD	B-VP	O
:	:	:	O	O
given	give	VBN	B-VP	O
250	250	CD	B-NP	O
cc	cc	NN	I-NP	O
NS	NS	NN	I-NP	O
;	;	:	O	O
internal	internal	JJ	B-NP	O
hemmorhoids	hemmorhoid	NNS	I-NP	O
seen	see	VBN	B-VP	O
on	on	IN	B-PP	O
anoscopy	anoscopy	NN	B-NP	O
Vitals	Vital	NNS	I-NP	O
:	:	:	O	O
74	74	CD	B-NP	O
vpaced	vpace	VBD	B-VP	O
,	,	,	O	O
148/82	148/82	CD	B-NP	O
,	,	,	I-NP	O
16	16	CD	I-NP	O
,	,	,	I-NP	O
98	98	CD	I-NP	O
RA	RA	NNP	I-NP	O
Exam	Exam	NNP	I-NP	O
:	:	:	O	O
obese	obese	JJ	B-ADJP	O
,	,	,	O	O
well	well	RB	B-ADJP	O
appearing	appear	VBG	I-ADJP	O
,	,	,	O	O
nad	nad	NN	B-NP	O
,	,	,	O	O
mmm	mmm	NN	B-NP	O
,	,	,	O	O
jvp	jvp	NN	B-NP	O
not	not	RB	B-VP	O
appreciated	appreciate	VBN	I-VP	O
,	,	,	O	O
lungs	lung	NNS	B-NP	O
clear	clear	JJ	I-NP	O
,	,	,	I-NP	O
obese	obese	JJ	I-NP	O
,	,	,	I-NP	O
rotund	rotund	NN	I-NP	O
abd	abd	NN	I-NP	O
,	,	,	O	O
bs	b	NNS	B-NP	O
present	present	JJ	B-NP	O
,	,	,	I-NP	O
rectal	rectal	JJ	I-NP	O
guiaic	guiaic	JJ	I-NP	O
positive	positive	JJ	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
BRBPR	BRBPR	NN	I-NP	B-protein
,	,	,	O	O
tender	tender	NN	B-NP	O
on	on	IN	B-PP	O
exam	exam	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
chronic	chronic	JJ	I-NP	O
L	L	NN	I-NP	O
>	>	SYM	B-NP	O
R	R	NN	I-NP	O
-LRB-	-LRB-	SYM	I-NP	O
chronic	chronic	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
pulses	pulse	VBZ	B-VP	O
nonpalpable	nonpalpable	JJ	B-NP	O
,	,	,	I-NP	O
mult	mult	JJ	I-NP	O
ulcers	ulcer	NNS	I-NP	O
of	of	IN	B-PP	O
R	R	NN	B-NP	O
shin	shin	NN	I-NP	O
erythematous	erythematous	JJ	B-ADJP	O
,	,	,	O	O
mildly	mildly	RB	B-NP	O
tender	tender	NN	I-NP	O
to	to	TO	B-PP	O
palpation	palpation	NN	B-NP	O
Studies	Study	NNS	I-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
EKG	EKG	NN	I-NP	B-protein
vpaced	vpace	VBN	B-VP	O
at	at	IN	B-PP	O
75	75	CD	B-NP	O
unchanged	unchanged	JJ	I-NP	O
A/P	A/P	NN	I-NP	O
:	:	:	O	O
Likely	Likely	RB	B-NP	O
diverticular	diverticular	JJ	I-NP	O
vrs	vr	NNS	I-NP	O
hemorrhoidal	hemorrhoidal	JJ	B-NP	O
bleed	bleed	NN	I-NP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
,	,	,	O	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
bleeding	bleeding	NN	I-NP	O
,	,	,	O	O
Hct	Hct	NN	B-NP	O
stable	stable	JJ	B-ADJP	O
,	,	,	O	O
needs	need	VBZ	B-VP	O
inpatient	inpatient	NN	B-NP	O
f/u	f/u	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
anticoagulation	anticoagulation	NN	B-NP	O
,	,	,	O	O
Problem	Problem	NNP	B-NP	O
List	List	NNP	I-NP	O
:	:	:	O	O
CV-Ischemia	CV-Ischemia	NNP	B-NP	O
ASA	ASA	NNP	I-NP	O
held	hold	VBD	B-VP	O
,	,	,	O	O
Cont	Cont	NNP	B-NP	O
BB	BB	NNP	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
Pump	Pump	NNP	I-NP	O
EF	EF	NNP	I-NP	O
50	50	CD	I-NP	O
%	%	NN	I-NP	O
Rhythm	Rhythm	NN	I-NP	O
monitor	monitor	NN	I-NP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
Resp-no	Resp-no	JJ	I-NP	O
actives	active	NNS	I-NP	O
issues	issue	NNS	I-NP	O
Renal-Cr	Renal-Cr	JJ	B-NP	O
function	function	NN	I-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
GI-2	GI-2	NN	I-NP	O
large	large	JJ	I-NP	O
bore	bore	JJ	I-NP	O
IVS	IVS	NN	I-NP	O
,	,	,	I-NP	O
T	T	NN	I-NP	O
and	and	CC	I-NP	O
H	H	NN	I-NP	O
;	;	:	O	O
GI	GI	NN	B-NP	O
consulted	consult	VBD	B-VP	O
,	,	,	O	O
recommend	recommend	VB	B-VP	O
colonscopy	colonscopy	NN	B-NP	O
on	on	IN	B-PP	O
8/4	8/4	CD	B-NP	O
s/p	s/p	NN	I-NP	O
colonscopy	colonscopy	NN	I-NP	O
described	describe	VBN	B-VP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
repeat	repeat	NN	B-NP	O
study	study	NN	I-NP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
PCP	PCP	NN	B-NP	O
will	will	MD	B-VP	O
f/u	f/u	VB	I-VP	O
EGD	EGD	NN	B-NP	O
biopsy	biopsy	NN	I-NP	O
,	,	,	O	O
cont	cont	NN	B-NP	O
nexium	nexium	NN	I-NP	O
40bowel	40bowel	NN	I-NP	O
regimen	regimen	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
,	,	,	O	O
outpatient	outpatient	NN	B-NP	O
GI	GI	NN	I-NP	O
f/u	f/u	NN	I-NP	O
Heme-Hct	Heme-Hct	NN	I-NP	O
41.1	41.1	CD	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
c/w	c/w	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
;	;	:	O	O
repeat	repeat	NN	B-NP	O
Hct	Hct	NN	I-NP	O
stable	stable	JJ	B-ADJP	O
;	;	:	O	O
INR	INR	NN	B-NP	O
therapeutic	therapeutic	JJ	B-ADJP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
at	at	IN	B-PP	O
3	3	CD	B-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
Vit	Vit	NNP	B-NP	O
K	K	NNP	I-NP	O
5mg	5mg	NN	I-NP	O
times	time	NNS	I-NP	O
one	one	CD	B-NP	O
to	to	TO	B-VP	O
reverse	reverse	VB	I-VP	O
given	give	VBN	I-VP	O
unclear	unclear	JJ	B-NP	O
severity	severity	NN	I-NP	O
of	of	IN	B-PP	O
bleeding	bleed	VBG	B-VP	O
at	at	IN	B-PP	O
onset	onset	NN	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
for	for	IN	B-PP	O
afib	afib	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
followed	follow	VBN	B-VP	O
in	in	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
clinic	clinic	NN	I-NP	O
at	at	IN	B-PP	O
GMMC	GMMC	NN	B-NP	B-protein
with	with	IN	B-PP	O
blood	blood	NN	B-NP	O
draws	draw	NNS	I-NP	O
at	at	IN	B-PP	O
Ban	Ban	NNP	B-NP	O
Will	Will	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
,	,	,	O	O
verified	verify	VBN	B-VP	O
with	with	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
clinic	clinic	NN	I-NP	O
,	,	,	O	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
twice	twice	RB	B-NP	O
weekly	weekly	JJ	I-NP	O
draws	draw	NNS	I-NP	O
pending	pende	VBG	B-PP	O
stabilization	stabilization	NN	B-NP	O
of	of	IN	B-PP	O
level	level	NN	B-NP	O
,	,	,	O	O
restarted	restart	VBD	B-VP	O
coumadin	coumadin	NN	B-NP	O
at	at	IN	B-PP	O
d/c	d/c	NN	B-NP	O
Endo-1	Endo-1	NN	I-NP	O
/	/	SYM	O	O
2	2	CD	B-NP	O
lantus	lantus	NN	I-NP	O
while	while	IN	B-SBAR	O
npo	npo	NN	B-NP	O
ID-R	ID-R	NN	I-NP	O
LE	LE	NN	I-NP	O
ulcers	ulcer	NNS	I-NP	O
concerning	concern	VBG	B-VP	O
for	for	IN	B-PP	O
developing	develop	VBG	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
,	,	,	O	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
doxycycline	doxycycline	NN	B-NP	O
will	will	MD	B-VP	O
complete	complete	VB	I-VP	O
10	10	CD	B-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
FEN-npo	FEN-npo	JJ	B-ADJP	O
with	with	IN	B-PP	O
gentle	gentle	JJ	B-NP	O
IVF	IVF	NN	I-NP	O
Pain-oxycodone	Pain-oxycodone	NN	I-NP	O
,	,	,	O	O
allopurinol	allopurinol	NN	B-NP	O
Neuro	Neuro	NN	I-NP	O
-	-	HYPH	B-NP	O
h/o	h/o	NN	I-NP	O
seizure	seizure	NN	I-NP	O
disorder	disorder	NN	I-NP	O
on	on	IN	B-PP	O
phenobarbital	phenobarbital	NN	B-NP	O
,	,	,	O	O
level	level	NN	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
,	,	,	I-NP	O
cont	cont	JJ	I-NP	O
PPx-PPI	PPx-PPI	NN	I-NP	O
,	,	,	O	O
pneumoboots	pneumoboot	NNS	B-NP	O
,	,	,	O	O
TEDS	TEDS	NNP	B-NP	O
Dispo-home	Dispo-home	NNP	I-NP	O
Code-FC	Code-FC	NNP	I-NP	O
ADDITIONAL	ADDITIONAL	NNP	I-NP	O
COMMENTS	COMMENTS	NNP	I-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
f/u	f/u	NN	B-NP	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	O
as	as	IN	B-PP	O
scheduled	schedule	VBN	B-NP	O
INR	INR	NN	I-NP	B-protein
checked	check	VBD	B-VP	O
at	at	IN	B-PP	O
Ebemill	Ebemill	NNP	B-NP	O
Mi	Mi	NNP	I-NP	O
Valley	Valley	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
on	on	IN	B-PP	O
Tues	Tues	NNP	B-NP	O
and	and	CC	I-NP	O
Fri	Fri	NNP	I-NP	O
Your	Your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
results	result	NNS	B-NP	O
EGD	EGD	NN	I-NP	O
biopsy	biopsy	NN	I-NP	O
rsulted	rsulte	VBD	B-VP	O
followe	followe	NN	B-NP	O
by	by	IN	B-PP	O
PCP	PCP	NN	B-NP	O
Return	Return	NN	I-NP	O
to	to	TO	B-PP	O
ED	ED	NN	B-NP	O
or	or	CC	I-NP	O
call	call	NN	I-NP	O
PCP	PCP	NN	I-NP	O
with	with	IN	B-PP	O
heavy	heavy	JJ	B-NP	O
bleeding	bleeding	NN	I-NP	O
or	or	CC	O	O
concerning	concern	VBG	B-NP	O
symptoms	symptom	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
dizzyness	dizzyness	NN	B-NP	O
or	or	CC	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
Repeat	Repeat	NN	I-NP	O
colonoscopy	colonoscopy	NN	I-NP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
years	year	NNS	I-NP	O
Follow	Follow	VBP	B-VP	O
electrolytes	electrolyte	NNS	B-NP	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	O
PCP	PCP	NN	I-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
progression	progression	NN	B-NP	O
of	of	IN	B-PP	O
cellulitis	cellulitis	NN	B-NP	O
on	on	IN	B-PP	O
antibiotic	antibiotic	JJ	B-NP	O
,	,	,	O	O
return	return	VB	B-VP	O
to	to	TO	B-PP	O
Ed	Ed	NNP	B-NP	O
with	with	IN	B-PP	O
fevers	fever	NNS	B-NP	O
or	or	CC	I-NP	O
chills	chill	NNS	I-NP	O
or	or	CC	O	O
increasing	increase	VBG	B-VP	O
redness	redness	NN	B-NP	O
or	or	CC	I-NP	O
pain	pain	NN	I-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
VILLARREAL	VILLARREAL	NNP	B-NP	O
,	,	,	O	O
ROOSEVELT	ROOSEVELT	NNP	B-NP	O
F.	F.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NM201	NM201	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
4/3/06	4/3/06	CD	I-NP	O
@	@	SYM	B-NP	O
03	03	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

